1. A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection. (7th December 2018) Authors: Yamamoto, Takuya; Masuta, Yuji; Momota, Masatoshi; Kanekiyo, Masaru; Kanuma, Tomohiro; Takahama, Shoukichi; Moriishi, Eiko; Yasutomi, Yasuhiro; Saito, Takashi; Graham, Barney S; Takahashi, Yoshimasa; Ishii, Ken J Journal: International immunology Issue: Volume 31:Number 2(2019) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Species‐dependent role of type I IFNs and IL‐12 in the CTL response induced by humanized CpG complexed with β‐glucan. Issue 5 (9th February 2016) Authors: Kobiyama, Kouji; Temizoz, Burcu; Kanuma, Tomohiro; Ozasa, Koji; Momota, Masatoshi; Yamamoto, Takuya; Aoshi, Taiki; Kuroda, Etsushi; Ishii, Ken J. Journal: European journal of immunology Issue: Volume 46:Issue 5(2016) Page Start: 1142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗